Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.
Yi-Chuan YuHung Nguyen LuuRenwei WangClaire E ThomasNancy W GlynnAda O YoukJaideep BehariWoon-Puay KohPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Clinical surveillance of serum iron level may be a potential strategy to identify patients with NAFLD who are at high risk for HCC.